medigraphic.com
SPANISH

Revista Cubana de Cardiología y Cirugía Cardiovascular

ISSN 1561-2937 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number 2

<< Back Next >>

Rev Cubana Cardiol Cir Cardiovasc 2013; 19 (2)

Hyperglycemia, prognosis marker of adverse events in heart attack

García CY, González RCM, Jorrín RFR, Valladares CFJ, Navarro LJJ, Castillo FS
Full text How to cite this article

Language: Spanish
References: 16
Page: 72-78
PDF size: 368.45 Kb.


Key words:

Myocardial infarction, glycemia, prognosis.

ABSTRACT

Introduction: Hyperglycemia on admission in patient with acute coronary syndrome is common, considered bad marker of clinical evolution and death.
Objective: To value the use of admission glycemia like prognosis factor of adverse events in patient with heart attack.
Method: Descriptive study and longitudinal prospective. 246 patients were included with heart attack admitted in Cienfuegos hospital and their evolution was continued during 30 days. It was determined as point of a very best cut for the mortality at admission glycemia ≥ 7,1mmol/l by means of the curve ROC and one carries out analysis logistics regression to identify independent predictors of death.
Results: The patients with glycemia ≥ 7,1mmol/l prevailed the diabetes, tachycardia, killip≥II, inferior localization, small ejection fraction and bigger incidence of adverse events (60% versus 2%, p=0,000) as heart failure(30% versus 15%; p = 0,001), malign ventricular arrhythmias (23% versus 4%; p = 0,000) and death(15% versus 3%; p = 0,001), with smaller survival regarding the patients with glycemia ‹7,1mmol/l(85,5% in contrast with 96,6%). Age and ejection fraction were independent predictors of death in the multivariate analysis.
Conclusions: In patient with myocardial infarction the hyperglycemia to the entrance, with a cut point ≥7,1mmol/l, predicts a short term increment of adverse events, although it was not independent predictor of death.


REFERENCES

  1. Cid-Álvarez B, Gude F, Cadarso-Suárez C, González-Babarro E, Rodríguez-Álvarez MX, García-Acuña JM, et al. Admission and fasting plasma glucose for estimating risk of death of diabetic and nondiabetic patients with acute coro-nary syndrome: nonlinearity of hazard ratios and time-dependent comparison. Am Heart J. 2009; 158:889-97. Dis-ponible en: http://www.ahjonline.com/article/S0002-8703(09)00780-7/abstract

  2. Kosiborod M, Inzucchi SE, Krumholz HM, Xiao L, Jones PG, and Fiske S, et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation. 2008; 117:1818-27. Dis-ponible en: http://www.ncbi.nlm.nih.gov/pubmed/18299511?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus

  3. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, et al. Hyperglycemia and acute coronary syn-drome. A scientific statement from the American Heart Asso-ciation Diabetes Committee of the Council on Nutrition, Phys-ical Activity, and Metabolism. Circulation. 2008; 117:1010-9. Disponible en: http://circ.ahajournals.org/content/vol117/issue12/

  4. Ceriello A. Acute hyperglycaemia: a new risk factor during myocardial infarction. Eur Heart J. 2005; 26:328-31. Disponi-ble en: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15618047&dopt=Abstract

  5. Zarich S, Nesto R. Implications and treatment of acute hyperglycemia in the setting of acute myocardial infarction. Circulation. 2007; 115:e436-39. Disponible en: http://circ.ahajournals.org/

  6. Monteiro S, Gonçalves F, Monteiro P, Freitas M, Pro-vidência L. Magnitud de la variación de la glucemia: ¿un nue-vo instrumento para la evaluación del riesgo en el síndrome coronario agudo? Rev Esp Cardiol. 2009; 62:1099-108. Dis-ponible en: http://www.revespcardiol.org/cardio/ctl_servlet?_f=45&ident=13141787

  7. Kosiborod M. Variación de la glucemia en pacientes hospi-talizados por infarto agudo de miocardio. ¿Es el momento de la glucometría? Rev Esp Cardiol. 2009; 62:1092-4. Disponi-ble en: http://www.revespcardiol.org/cardio/ctl_servlet?_f=7&ident=13007698

  8. Curós A, Serra J. Relevancia de la hiperglucemia en el síndrome coronario agudo. Rev Esp Cardiol. 2008; 61:447-50. Disponible en: http://www.revespcardiol.org/cardio/ctl_servlet?_f=40&ident=13119986

  9. Macín S, Perna E, Coronel M, Kriskovich J, Bayol P, Fran-ciosi V, et al. Influencia de la concentración de glucemia en el momento del ingreso en la evolución a largo plazo de los pa-cientes con síndrome coronario agudo. Rev Esp Cardiol. [In-ternet]. 2006; 59h12min-75. Disponible en: http://www.revespcardiol.org/cardio/ctl_servlet?_f=7&ident=13004158

  10. Rocha S, Nabais S, Magalhaes S, Salgado A, Azavedo P, Marques J, et al. Glicemia na admissao: Factor predictivo de morte após Síndrome Corária Aguda em doentes nao diabé-ticos? Rev Port Cardiol. 2007; 26:1367-77.

  11. Vivas D, García-Rubira JC, González-Ferrer JJ, Núñez-Gil I, Del Prado N, Fernández-Ortiz A, et al. Valor pronóstico de la primera glucemia en ayunas en comparación con la gluce-mia al ingreso en pacientes con síndrome coronario agudo. Rev Esp Cardiol. 2008:61:458-64. Disponible en: http://www.revespcardiol.org/cardio/ctl_servlet?_f=7&ident=13006208

  12. Panduranga P, Sulaiman K, Al-Lawati J, Al-Zakwani I. Rela-tionship between admitting nonfasting blood glucose and in-hospital mortality stratified by diabetes mellitus among acute coronary syndrome patients in Oman. Heart Views. 2011; 12:12-7. Disponible en: http://dx.crossref.org/10.4103%2F1995-705X.81554

  13. Nordin C, Amiruddin R, Rucker L, Choi J, Kohli A, Marantz PR. Diabetes and stress hyperglycemia associated with myo-cardial infarctions at an urban municipal hospital: prevalence and effect on mortality. Cardiol Rev. 2005; 13:223-30. Dispo-nible en: http://www.pubmed.gov/

  14. Sanjuán R, Núñez J, Blasco ML, Miñana G, Martínez H, Carbonell N, et al. Implicaciones pronósticas de la hiperglu-cemia de estrés en el infarto agudo de miocardio con eleva-ción del ST. Estudio observacional prospectivo. Rev Esp Cardiol. 2011; 64:201-7. Disponible en: http://www.revespcardiol.org/sites/default/files/elsevier/pdf/25/25v64n03a90000662pdf001.pdf

  15. Sinnaeve PR, Steg PG, Fox KA, Van de Werf F, Montalescot G, Granger CB, et al. Association of elevated fasting glucose with increased short- term and 6-month mortality in ST-segment elevation and non-ST- segment elevation acute co-ronary syndromes: the Global Registry of Acute Coronary Events. Arch Intern Med. 2009; 169:402-9. Disponible en: www.ncbi.nlm.nih.gov/pubmed?term=%22Sinnaeve%20PR%22%5BAuthor%5D

  16. Egi M, Bellomo R, Stachowski E, French CJ, Hart G, Stow P. Circadian rhythm of blood glucose values in critically ill pa-tients. Crit Care Med. 2007; 35:416-21. Disponible en: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17205020&dopt=Abstract




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Cardiol Cir Cardiovasc. 2013;19